The ARRIVE Trial: towards a universal recommendation of induction of labour at 39 weeks?

Publication date: Available online 11 November 2019Source: European Journal of Obstetrics &Gynecology and Reproductive BiologyAuthor(s): Federico Migliorelli, Sara S. De Oliveira, Begoña Martínez de TejadaAbstractBoth caesarean surgery and induction of labour are common practices performed in all labour wards in an attempt to reduce adverse obstetrical and neonatal outcomes. Recent evidence, notably from the ARRIVE Trial, demonstrated that elective induction at 39 weeks reduced the rate of caesarean deliveries and pregnancy-related hypertensive disorders. However, some concerns have to be addressed as the benefits of universal policies have to be weighed against the actual circumstances of their implementation, the economic impact, the number of procedures needed in order to effectively reduce complications and, above all, women’s perception towards this approach at the end of pregnancy. Further research is needed to explore individual tailored strategies in order to offer a personalized prognosis to each woman, rather than a blanket application of general recommendations.
Source: European Journal of Obstetrics and Gynecology and Reproductive Biology - Category: OBGYN Source Type: research

Related Links:

CONCLUSION: Women with refractory PPH showed a different pattern of maternal characteristics and PPH causes compared to those with first-line treatment responsive PPH. PMID: 31808245 [PubMed - as supplied by publisher]
Source: BJOG : An International Journal of Obstetrics and Gynaecology - Category: OBGYN Authors: Tags: BJOG Source Type: research
Publication date: December 2019Source: Canadian Journal of Diabetes, Volume 43, Issue 8Author(s): Alexandra Pouliot, Riham Elmahboubi, Catherine AdamAbstractObjectivesAt 1 Canadian university hospital, pregnant women were routinely screened for gestational diabetes mellitus (GDM) with a 75-g oral glucose tolerance test (OGTT). Diagnostic plasma glucose thresholds were as follows: fasting: ≥5.3 mmol/L, 1 h: ≥10.6 mmol/L and 2 h: ≥9.0 mmol/L. In 2015, diagnostic thresholds were reduced to those recommended by the International Association of Diabetes in Pregnancy Study Group (IADPSG) as follows: fasting: ≥5.1 mmo...
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
To determine the risk of cesarean delivery after labor induction among patients with prior placenta-mediated pregnancy complications (pre-eclampsia, late pregnancy loss, placental abruption or intrauterine gro...
Source: BMC Pregnancy and Childbirth - Category: OBGYN Authors: Tags: Research article Source Type: research
(BMJ. 2019;364:I344) Because of the fact that postterm pregnancy (defined as pregnancy extended to or beyond 42 weeks gestation) has been associated with increased perinatal morbidity and mortality, induction of labor is recommended after 42 weeks gestation. Although the probability of positive outcomes for neonates born between 40 and 42 weeks gestation is overall considered good, the risk of adverse outcomes has been shown to increase gradually after 40 weeks gestation. Several studies have found that induction of labor at 41 weeks gestation and later, rather than waiting for the onset of spontaneous labor improves peri...
Source: Obstetric Anesthesia Digest - Category: Anesthesiology Tags: Mother, Fetus, Neonate Source Type: research
(BMJ. 2019;364:1681) Most pregnant women want clear and accurate evidence-based information to help them make decisions about their labor and delivery experience. When confronted with a “postterm” pregnancy, which poses increased risks for women and their babies, this information is especially important. A recent Cochrane systematic review reported that induction at or beyond the due date was associated with fewer perinatal deaths, neonatal admissions to intensive care, and cesarean sections but more operative vaginal births when compared with expectant management. This editorial discussed previous studies and...
Source: Obstetric Anesthesia Digest - Category: Anesthesiology Tags: Mother, Fetus, Neonate Source Type: research
This study aimed to compare neonatal and maternal outcomes in women undergoing elective induction of labor at 39 weeks gestation or beyond with the outcomes of women whose pregnancies were managed expectantly.
Source: Obstetric Anesthesia Digest - Category: Anesthesiology Tags: Mother, Fetus, Neonate Source Type: research
It's widely believed that mothers and babies have an increased risk of problems at or beyond 42 weeks of pregnancy.
Source: WebMD Health - Category: Consumer Health News Source Type: news
THURSDAY, Nov. 21, 2019 -- In women with a low-risk pregnancy, induction at 41 weeks of gestation may be safer than a wait-and-see approach to 42 weeks, according to a study published online Nov. 20 in The BMJ. Ulla-Britt Wennerholm, M.D., Ph.D.,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
(University of Gothenburg) Inducing labor after 41 instead of 42 full weeks' pregnancy appears to be safer in terms of perinatal survival, new Swedish research shows. The current study is expected to provide a key piece of evidence for upcoming decisions in maternity care.
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news
Background: It is unclear whether sarcoidosis, a multisystem inflammatory disease, is associated with adverse pregnancy outcomes.Aim: To assess the risk of adverse maternal and fetal outcomes in sarcoidosis pregnancies.Methods: Using a population-based cohort study design and Swedish national registers (2002-2013), we identified 764 singleton pregnancies (258 first pregnancies) in the Medical Birth Register with at least one maternal ICD-coded sarcoidosis visit prior to pregnancy in the National Patient Register. Modified Poisson regression models adjusted for age at delivery, calendar year and educational level estimated ...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Sarcoidosis and other granulomatous ILD/DPLD Source Type: research
More News: Biology | Induction of Labor | OBGYN | Perinatology & Neonatology | Pregnancy | Women